Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation today

A Gratwohl1

  • 1Department of Internal Medicine, Kantonsspital, Basel, Switzerland.

Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants.

Leukemia·2017
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017
Same author

Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.

Leukemia·2017
Same author

Latin America: the next region for haematopoietic transplant progress.

Bone marrow transplantation·2017
Same author

The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.

Bone marrow transplantation·2016
Same author

Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT.

Leukemia & lymphoma·2016
Same journal

Photobiomodulation to prevent oral mucositis and physical function impairments after hematopoietic cell transplantation: POMFITT randomized trial.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Evaluating the role of survivorship care plans in modifying disparities in health status among female cancer survivors in Maryland.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Personal pathways to success: an innovative program to overcome cancer patient barriers to tobacco cessation and promote patient participation.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Association of social determinants of health and physical functioning among breast cancer survivors.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Symptoms experienced during the first 4 months of chemotherapy administration: a longitudinal cohort study in an Australian cancer treatment unit.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same journal

Diagnosis and management of immune checkpoint inhibitor-induced dry mouth and salivary gland dysfunction in oncology patients: a systematic review.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
See all related articles

Bone marrow transplantation (BMT) is a well-established therapy, with over 14,000 procedures performed in Europe between 1990-1992. Outcomes depend on various factors, allowing for personalized risk assessment and treatment adjustment.

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Bone marrow transplantation (BMT) has evolved into an established therapeutic modality.
  • The widespread application of BMT necessitates a comprehensive understanding of its utilization and outcomes.

Purpose of the Study:

  • To analyze the volume and scope of bone marrow transplant procedures performed across Europe.
  • To identify key factors influencing transplant outcomes and inform personalized treatment strategies.

Main Methods:

  • Retrospective analysis of 14,334 bone marrow transplants conducted by 172 European teams between January 1990 and December 1992.
  • Categorization of transplants into allogeneic and autologous procedures, detailing specific types and indications.

Related Experiment Videos

Main Results:

  • A total of 14,334 transplants were performed, comprising 6,642 allogeneic and 7,692 autologous procedures.
  • Leukemias (52%) were the primary indication, followed by lymphoproliferative disorders (29%) and solid tumors (11%).
  • Established factors influencing outcomes include disease characteristics, patient/donor demographics, and treatment protocols.

Conclusions:

  • Bone marrow transplantation is a significant therapeutic intervention with diverse applications.
  • Understanding prognostic factors is crucial for optimizing patient selection and tailoring treatment regimens.
  • Continued research and data analysis are vital for advancing BMT efficacy and patient survival rates.